News

Published on 20 Jun 2024 on Zacks · via Yahoo Finance

ImmunityBio (IBRX) Gains 17% in the Past Week: Here's Why

Article preview image

ImmunityBio’s IBRX commercial portfolio comprises its only marketed drug, Anktiva (N-803, or nogapendekin alfa inbakicept-pmln).

Anktiva, in combination with Bacillus Calmette-Guérin (BCG), got FDA approval in April 2024 for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors.

Read the rest of the article
NASDAQ.IBRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Immunitybio Inc. (IBRX): Among the Most Promising Cancer Stocks According to...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In t...

Insider Monkey · via Yahoo Finance 23 Nov 2024
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder...

EF Hutton has initiated coverage on ImmunityBio Inc. (NASDAQ:IBRX), a vertically integrated...

Benzinga · via AOL 25 Oct 2024
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder...

EF Hutton has initiated coverage on ImmunityBio Inc. (NASDAQ:IBRX), a vertically integrated...

Benzinga · via Yahoo Finance 23 Oct 2024
Immunitybio Inc. (IBRX): Fast-Growing Penny Stock To Consider

We recently compiled a list of the 10 Best Fast-Growing Penny Stocks to Buy Now. In this article,...

Insider Monkey · via Yahoo Finance 21 Sep 2024
ImmunityBio (IBRX) Gains 17% in the Past Week: Here's Why

ImmunityBio’s IBRX commercial portfolio comprises its only marketed drug, Anktiva (N-803, or noga...

Zacks · via Yahoo Finance 20 Jun 2024
Why EV-Maker Mullen Automotive's Stock Is Charging Monday - Mullen Automotive (NASDAQ:MULN)

Mullen Automotive, Inc. MULN shares are trading higher Monday after the company announced the Cal...

Benzinga 29 Apr 2024
What's Going On With Super Micro Computer Stock Ahead Of Earnings? - Super Micro Computer...

Super Micro Computer, Inc. SMCI shares are trading higher Monday, and the stock is up more than 2...

Benzinga 29 Apr 2024
ImmunityBio Drug Gets FDA Nod - Los Angeles Business Journal

Approval clears way for distribution.

Los Angeles Business Journal 29 Apr 2024
ImmunityBio shares target raised on Anktiva pricing strategy By Investing.com

On Monday, ImmunityBio Inc (NASDAQ:IBRX) saw its price target increased by Piper Sandler from $5....

Investing.com 29 Apr 2024
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.40% By Investing.com

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.40%

Investing.com 26 Apr 2024

Copyright Statfolio @ 2024

Social Accounts